tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, cellulosum microcristallinum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 7.28 µg, triethylis citras, talcum, Kapselhülle: gelatina, E 132, E 171, E 172 (rubrum), E 172 (flavum), E 172 (nigrum) pro capsula.
Packungsbestandteile
Delayed release capsules
Active Agent
Dose
Tamsulosine Hydrochloride
0.4 mg correspond Tamsulosinum 0.367 mg
BAG: Active Agent
Dose
Tamsulosine Hydrochloride
0.4 mg
Inactive agents
additional_information
(Flavum)
(Nigrum) pro Capsula
(Rubrum)
Acidi Methacrylici
Cellulosum Microcristallinum
E 132
color.
E 171
color.
E 172
color.
Ethylis Acrylatis Polymerisatum Dispersio 30 per Centum cum Polysorbatum 80
Gelatina
Kapselhülle
Natrii Laurilsulfas
Talcum
Triethylis Citras
Source
Data was imported : 05.05.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
